Delivery system for deployment of medical devices

Information

  • Patent Grant
  • 8986361
  • Patent Number
    8,986,361
  • Date Filed
    Friday, October 17, 2008
    16 years ago
  • Date Issued
    Tuesday, March 24, 2015
    9 years ago
Abstract
A sheathed catheter system is described where the sheath comprises a distal portion and a proximal portion that are moveable axially relative to each other, and relative to a tube carrying a medical device thereon. The distal and proximal sheath portions can be brought together in order to enclose therewithin the medical device. The distal sheath has a proximal section that is configured to bias radially inwardly to minimize an otherwise exposed annular surface catching on protruding surfaces that may exist on the catheter or other medical tool in use at the time, or to minimize scraping the inner native lumen of the patient upon retrieval.
Description
BACKGROUND OF THE INVENTION

1. Field of the Invention


The present invention relates generally to an apparatus and method for deploying a medical device from a minimally invasive delivery system, such as a delivery catheter, and deploying the device within a patient.


2. Description of the Related Art


Percutaneous aortic valve replacement (PAVR) technology is emerging that provides an extremely effective and safe alternative to therapies for aortic stenosis specifically, and aortic disease generally. Historically, aortic valve replacement necessitated open heart surgery with its attendant risks and costs. The replacement of a deficient cardiac valve performed surgically requires first placing the patient under full anesthesia, opening the thorax, placing the patient under extracorporeal circulation or peripheral aorto-venous heart assistance, temporarily stopping the heart, exposing and excising the deficient valve, and then implanting a prosthetic valve in its place. This procedure has the disadvantage of requiring prolonged patient hospitalization, as well as extensive and often painful recovery. Although safe and effective, surgical aortic valve replacement (SAVR) presents advanced complexities and significant costs. For some patients, however, surgery is not an option for one or many possible reasons. As such, a large percentage of patients suffering from aortic disease go untreated.


To address the risks associated with open-heart implantation, devices and methods for replacing a cardiac valve by less invasive means have been developed. For example, CoreValve, Inc. of Irvine, Calif. has developed a prosthetic valve fixed to a collapsible and expandable support frame that can be loaded into a delivery catheter. Such a bioprosthesis may be deployed in-situ minimally invasively through the vasculature at significantly less patient risk and trauma. A description of the CoreValve bioprosthesis and various embodiments appears in U.S. Pat. Nos. 7,018,406 and 7,329,278, and published Application Nos. 2004/0210304 and 2007/0043435. By using a minimally invasive replacement cardiac valve, patient recovery is greatly accelerated over surgical techniques. In the case of the CoreValve device, the support frame is made from shape memory material such as Nitinol. Other catheter-delivery valve replacement systems use stainless steel, or do not rely upon a rigid frame.


As demonstrated successfully to date, using a transcatheter procedure, percutaneous aortic valve replacement proceeds by delivering a prosthetic valve to the diseased valve site for deployment, either using a balloon to expand the valve support against the native lumen or exposing a self-expanding support in situ and allowing it to expand into place. With the latter, the self-expanding frame remains sheathed during delivery until the target site is reached. Advantageously, the frame may be secured to the catheter to avoid premature deployment as the sheath is withdrawn. In the CoreValve valve prosthesis, a hub is employed with two lateral buttons or ears around each of which a loop or alternatively a frame zig may reside during delivery. The internal radial force of the sheath keeps the frame compressed against the catheter, including the frame zigs in place around the lateral buttons. The catheter generally comprises at least two tubes, an inner tube that carries the prosthesis and a central tube that carries the sheath, permitting the sheath to move relative to the prosthesis.


As with traditional cardiovascular interventional therapies, transcatheter device deployment may proceed retrograde against normal blood flow, or antegrade, with blood flow. For percutaneous aortic valve replacement, entry through the femoral arteries proceeds in a retrograde format up through the iliac, the descending aorta, over the arch and to the native annulus. In some cases, entry has been made closer to the arch; for example through the left subclavian artery. Antegrade procedures have been performed where delivery takes place through the venous system transeptally to the native aortic annulus. More recently, transapical procedures have been performed whereby a cardiac surgeon delivers a catheter through the patient's chest wall, then through the exposed left ventricle apex and then to the target site.


With retrograde deployment, it is generally desired that the catheter be advanced within the vasculature so that the device is positioned where desired at the annulus site. With some embodiments under development, the desired site is the annulus itself With the CoreValve device, the desired site extends from the annulus to the ascending aorta, given its relative length. In the transfemoral approach, when the CoreValve device is positioned at the desired site, the sheath is withdrawn to the point where the inflow end of the device (preferably positioned at the native annulus) expands to engage and push radially outwardly the native valve leaflets. The sheath continues to be withdrawn proximally as the prosthesis continues to expand as it is exposed until the sheath covers just the outflow portion of the prosthesis still secured to the hub ears. Any readjustment of the axial position of the device in situ can be made during this process based upon electronic visual feedback during the procedure. Once well positioned, the sheath is fully withdrawn, the device fully expands in place, and the catheter is withdrawn through the center of the device and out through the vasculature. While it would be possible to deploy the prosthetic device such that the sheath could be withdrawn distally so that the outflow end of the prosthesis deploys first, such an arrangement would require advancing distally the central tube of the catheter connected to the sheath distally. In the case of transfemoral retrograde delivery, that would cause the central tube to project well into the left ventricle, which is not desirable. In a antegrade approach, for example transapical delivery, the reverse situation exists. There it is more desirable to advance the sheath distally to expose the inflow end of the prosthesis at the native annulus first. The native anatomy can accommodate this distal deployment because the central tube carrying the sheath is advanced up the ascending aorta towards the arch. Like the retrograde approach, once the valve prosthesis is fully deployed, the catheter may be withdrawn through the center of the prosthesis and removed through the apex of the heart.


Regardless of the direction of approach, with self-expanding frame technology, it is sometimes observed that even well-placed prosthetic valves inadvertently shift from the intended target site a small distance during the final delivery stage. The valve may still function effectively, but it is not optimized when, for example, the valve is placed so that it projects more than desired into the left ventricle. If the frame is implanted too low into the left ventricle, there is a risk of paravalvular leak where a portion of the blood ejected from the ventricle returns through the frame below the annulus.


In doing so, the catheter may sometimes inadvertently advance into the left ventricle for one of several possible reasons. One theory is that conical expansion of the zigs of the frame may influence positioning by following the path of least resistance until the inflow section is completely deployed in both the annulus and the ascending aorta may cause the prosthesis to shift. Another is the friction between the catheter sheath and the vessel wall, which may limit retraction of sheath even though the operator is pulling on it through the handle button. Consequently, the valve is pushed distally through the forward action of the plunger rather than the valve remaining stationary relative to the target site by the retraction of the sheath in the proximal direction. If the valve is not fully deployed (i.e., the sheath is not fully retracted) so that the valve frame is still secured to the catheter, axial adjustment is still possible. This is known as dynamic catheter positioning. In some cases, however, it is not determined until after full deployment that the frame is deployed amiss. In that circumstance, a repositioning procedure might need to be taken to correct placement. While possible in one of several different ways, it adds a level of complexity to the medical procedure that would be preferably avoided if possible. The problem is exacerbated because with transcatheter delivery, unlike surgical implantation, the clinician is unable to directly see the target site and must rely upon videographic technology to assess appropriate placement of the prosthesis.


One solution is to split the sheath into two discrete sections; a proximal section and a distal section. Doing so permits a controlled deployment that is central to the device, rather than at the distal or proximal end as with a single sheath. In U.S. Pat. No. 7,238,197, Seguin et al. have suggested such an arrangement, without any specificity or demonstration. See col. 14:36-42. No mention is made of the benefits or advantages of doing so, nor the particular configuration. Another example is shown in U.S. Pat. No. 7,022,133 to Yee et al. However, the distal and proximal portions are overlapping. Moreover, that disclosure does not address the issue regarding minimizing inaccurate deployment once the prosthesis is positioned at the target site. With an ill-configured split sheath arrangement, it has been observed that withdrawal of the catheter post-deployment may cause the proximal portion of the distal sheath to cause trauma to the native lumen where the vasculature is arcuate, such as the aortic arch. The problem may be encountered regardless of whether delivery proceeds antegrade or retrograde.


It is therefore desired to provide a transluminal catheter that enables prosthesis implantation accurately at the target location without the need for dynamic catheter positioning upon sheath retrieval. It is expected that, with such a solution, the prosthesis implantation procedure would become easier to manage with the desirable result that final positioning becomes more consistent.


SUMMARY OF THE INVENTION

The invention described and claimed herein comprises embodiments for minimally invasively delivering a medical device to a patient. The apparatus comprises a sheathed catheter system comprising an inner tube and a central tube, wherein the central tube has an outside surface suitable for accepting a medical device collapsed thereon in a stationary fashion. The sheath comprises a distal portion and a proximal portion that are moveable axially relative to each other, and with respect to the central tube, and can be brought together to abut in order to enclose therewithin a bioprosthesis such as a self-expanding frame supporting a tissue valve. In one embodiment, the distal sheath has a proximal section that is configured to bias radially inwardly to minimize a larger exposed annular surface that may catch on protruding surfaces or may scrape the native lumen surface of the patient upon retrieval. In another embodiment, a retaining hub for retaining a portion of the medical device being delivered comprises an extended portion that is generally cylindrical, or may have a non-tapered surface, such that it is configured to maintain low profile engagement with the distal sheath portion. Such an arrangement can also, when the distal sheath is retrieved, minimize vascular trauma or avoid being impeded by irregular surfaces. As contemplated, there are several different embodiments that can be made to employ the invention claimed herein. These and other features, aspects and advantages of embodiments of the present invention are described in greater detail below in connection with drawings of the apparatus and method, which is intended to illustrate, but not to limit, the embodiments of the present invention.


Thus one embodiment of the invention provides an apparatus for minimally invasively delivering a medical device to a target site within a patient, the apparatus comprising a first tube having an outside surface suitable for accepting a medical device collapsed thereon in a stationary position; and a sheath comprising first and second portions that may be moved axially relative to each other and with respect to the first tube, the sheath portions configured so as to enclose a medical device collapsed onto the first tube when brought together, and configured to expose the medical device when directed away from each other, the first sheath portion comprising a section that is normally biased radially inwardly so as to maintain a low profile.


Another embodiment of the invention provides an apparatus for delivering a medical device to a target site within a patient via a body lumen, the apparatus comprising: an inner tube; a distal sheath portion attached to the inner tube; an intermediate tube, moveable over the inner tube and at least partially into the distal sheath portion; an outer tube, moveable over the intermediate tube; a proximal sheath portion attached to the outer tube, so that, in use, the proximal sheath portion and the distal sheath portion can be moved together to substantially cover a medical device mounted on the intermediate tube and moved apart to deploy the medical device; the distal sheath portion having a proximal end portion configured to extend away from the walls of the body lumen when, in use, the sheath portions are apart and the distal sheath portion is moved proximately.


Another embodiment of the invention provides an apparatus for minimally invasively delivering a medical device to a target site within a patient, the apparatus comprising: a first tube having an outside surface suitable for accepting a medical device collapsed thereon in a stationary position, the first tube comprising a hub for retaining at least a portion of a medical device on the first tube, wherein the hub comprises a generally extended non-tapered portion; and a sheath comprising first and second portions that may be moved axially relative to each other and with respect to the first tube, the sheath portions configured so as to enclose a medical device collapsed onto the first tube when brought together, and configured to expose the medical device when directed away from each other; wherein, during operation, the first sheath portion may be moved in a direction sufficient to expose the medical device while said first sheath portion still covers at least a part of the extended non-tapered portion of the hub.


Yet another embodiment of the invention provides an apparatus for delivering a medical device to a target site within a patient via a body lumen, the apparatus comprising: an inner tube; a distal sheath portion attached to the inner tube; an intermediate tube, moveable over the inner tube and at least partially into the distal sheath portion, the intermediate tube having a hub at its distal end and having a region on the intermediate tube proximal of the hub for mounting the medical device; an outer tube, moveable over the intermediate tube; a proximal sheath portion attached to the outer tube, so that, in use, the proximal sheath portion and the distal sheath portion can be moved together to substantially cover a medical device mounted on the intermediate tube and moved apart to deploy the medical device; the hub having an axial length sufficient to permit the medical device to be deployed while the distal sheath portion covers at least part of the hub.





BRIEF DESCRIPTION OF THE DRAWINGS


FIGS. 1A and 1B show schematic views of a catheter having a sheath with distal and proximal portions.



FIGS. 2A and 2B show schematic views of the catheter of FIGS. 1A and 1B inserted within the vasculature.



FIGS. 3A-E show cross-sectional views of one embodiment of a device delivery system showing sequential axial movement of proximal and distal sheath portions.



FIGS. 3F and 3G show schematic views of the delivery system of FIGS. 3A-E.



FIGS. 4A-D show cross-sectional and schematic views of a second embodiment of a device delivery system showing sequential axial movement of distal sheath relative to an internal tube.





DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENT

Referring to FIGS. 1A and 1B, an example of a split sheath delivery system embodiment 10 for delivering a medical device 12 comprises a catheter 14 having a proximal end 16 and a distal end 18. In the figures shown, and by way of example, the medical device 12 is a self-expanding frame.


The split sheath catheter 14 of FIGS. 1A and 1B comprises a first inner tube 22 and a central tube 24, all of which may be controlled by the clinician. At the distal end of the central tube 24 is a hub or cap 26 affixed to the central tube 24. The hub 26 is preferably tapered distally and configured to have a smooth rounded surface at its distal-most end. The hub is further configured to comprise at least one but preferably two or more buttons 28 for assisting in retaining the medical device 12 until full deployment. Depending upon the configuration and arrangement, as well as semantics, the buttons may be described as projecting ears, tabs, or hooks. It is important to note that a hub is not required for the invention described herein.


The catheter 14 further comprises a sheath 30 preferably made of resilient pliable material, such as those used in the industry. The sheath may comprise in whole or in part a braided, woven, or stitched structure, a polymer, or may comprise an inflatable balloon. The sheath 30 comprises a distal portion 32 and a proximal portion 34 that when pulled together to form joint 36 fully enclose the medical device 12 within. A first end 38 of distal sheath portion 32 is affixed to the central surface of inner tube 22 proximal its distal end 18. The proximal sheath portion 34 is affixed at its proximal end 40 to an exterior tube 44 that extends in the proximal direction and covers both the proximal portions of central tube 24 and inner tube 22 in a preferably concentric configuration.


As shown in FIG. 1A, when the distal and proximal portions 32, 34 of sheath 30 are adjoined at joint 36, the medical device 12 is covered, thus permitting delivery of the medical device 12 to the desired target site. As shown in FIG. 1B, when the distal and proximal portions 32, 34 of sheath 30 are directed away from each other, the medical device 12 is exposed and permitted to expand. Referring to FIGS. 2A and 2B, one limitation with a split sheath arrangement may be appreciated. FIG. 2A shows a split sheath catheter embodiment similar to the one illustrated in FIGS. 1A-B and inserted within a patient's vasculature; in particular, the aortic arch 50 (with peripheral vessels not shown). When the distal and proximal sheath portions 32, 34 are directed apart, the central tube 24 carrying the medical device (not shown) is exposed so that the medical device may be released. Upon retrieval of the distal sheath 32, however, given the curvilinear nature of the native vasculature, the proximal end 48 of distal sheath 32 is pressed tightly up against the endothelial lining of the native lumen. Movement of the proximal end 48 in a proximal direction may cause trauma to the vasculature. Moreover, in a split sheath catheter embodiment where a hub 26 is employed or where the hub has buttons 28 that extend radially outward, the proximal end 48 of distal sheath 32 may also catch on the buttons 28 as the distal sheath is moved proximally.


In an effort to avoid these issues, another embodiment of split sheath catheter, shown in FIGS. 3A through 3G, comprises a distal sheath having an inwardly biased proximal section. Specifically, alternative split sheath delivery embodiment 110 for delivering a medical device 112 comprises a catheter 114 that comprises an inner tube 122 (with an optional internal lumen for passing a guide wire therethrough) where the inner tube 122 is concentrically positioned within a central tube 124. In the embodiment illustrated, the medical device 112 can be a self-expanding frame supporting a valve such as CoreValve's aortic valve prosthesis.


At the distal tip of the central tube 124 is a hub 126 having a generally tapered distal configuration and at least one but preferably two or more buttons 128 (FIG. 3D) for retaining the medical device 112 during travel. Enclosing the central tube 124, hub 126 and medical device 112 is split sheath 130 comprising a distal sheath portion 132 and proximal sheath portion 134 that are configured to abut together at joint 136 to fully enclose the medical device 112 therewithin. The distal sheath portion 132 comprises a tapered section 138 affixed to the distal end of inner tube 122. The proximal sheath portion 134 comprises a proximally tapered section 140 that forms external tube 144 controllable by the clinician. It should be noted that the relative size of the distal sheath 132 to the proximal sheath 134 is not critical, so it may be a ratio of 50/50 or a ratio where one is larger than the other.


When it is desired to expose the medical device 112, the distal sheath portion 132 is directed in the distal direction 160 while the proximal sheath portion 134 is directed in the proximal direction 170. In preferably stepped deployment fashion, the distal and proximal sheath portions 132, 134 are directed moved away from each other to the point that each portion still retains the respective distal end 112A and proximal end 112B of the medical device 112. The sequence of movement is not critical; i.e., it is not critical whether the proximal sheath is directed proximally before or after the distal sheath is directed distally. The distal sheath portion 132 is moved distally by directing the inner tube 122 distally 160, while the proximal sheath portion 134 may be moved proximally by pulling the external tube 144 in the proximal direction 170. By stepped deployment, more accurate placement of the medical device at the target site may be permitted. When the mid-portion of the medical device 112 expands to engage the luminal surface of the vasculature, the clinician can assess whether it is placed in situ at the desired location. If not, the catheter system 114 may be moved into either distally or proximally as needed.


When it is determined that the medical device 112 is properly positioned, the proximal sheath portion 134 may be further moved proximally to expose the proximal end 112B of the medical device and permit expansion thereof, as shown in FIG. 3C. With the medical device 112 more firmly positioned in the vasculature, the distal sheath portion 132 may be advanced further distally to release the distal end 112A of the medical device. The medical device is now fully deployed, as shown in FIG. 3D. Preferably, the distal sheath portion 132 has a proximal section 148 that is configured to radially bias inwardly when unconstrained. By continuing to advance the distal sheath portion 132 in the distal direction 160 beyond the axial position of the hub 126, the proximal section 148 of the distal sheath portion 132 collapses inwardly toward the inner tube 122. This reduces the profile of the distal sheath portion 132. The proximal section 148 of distal sheath 132 may be made of a membrane (e.g., polyurethane, silicon, etc.) elastically expandable up to a given diameter to host the prosthesis, or a generally cylindrical layer that can fold back along predetermined pleats to a smaller profile (e.g., ePTFE, Dacron™, etc.) so that its natural state is to be collapsed. Preformed polymeric material, encapsulated spring material or the like, are contemplated. Alternatively, it could be made with longitudinal splits inside a conventional sheath that tend to fold back towards the inner side when a given radial force (of the folded prosthesis) is removed; or it could be made by expansion of elastic material. Other materials and/or other modes of preparing the sheath 130 for effective function are also contemplated to achieve the functions described herein.


By either withdrawing the inner tube 122 with distal sheath portion 132 proximally, or by advancing the central tube 124 and hub 126 distally (as shown in FIGS. 3E and 3F), the distal sheath portion 132 may enclose the hub 126. The resilient nature of the proximal section 148 permits it to be expanded so as to permit the hub 126 to advance within the distal sheath portion 132. With this arrangement, a smoother and lower profile is created for withdrawing the catheter through the medical device 112 in the proximal direction 170, as shown in FIG. 3F.


Referring to FIGS. 4A-4D, an alternative embodiment catheter 214 comprises similar components as described above, including a central tube 224 with hub 226 at a distal end thereof. The catheter system 214 further comprises a distal sheath portion 232 having a proximal section 248 enclosing the distal end 212A of medical device 212. When being delivered to the target site, the distal sheath portion 232 encloses the hub 226. After proper placement of the medical device 212 in situ, the medical device may be fully deployed, as shown in FIG. 4B, by advancing the distal sheath portion 232 distally to expose the distal end 212A of the medical device. In this embodiment, it is contemplated that the hub 226 have an elongate configuration with an extended cylindrical portion 260 that results in a hub 226 longer than the hubs 26 and 126 of other embodiments described herein. With this configuration, the distally-advanced distal sheath portion 232 need not advance beyond the distal end of hub 226 (see FIGS. 4B and 4C). The distal sheath portion 232 may maintain a low profile by remaining biased against the hub 226 for retrieval through the deployed medical device 212. This may also be advantageous where it is preferred not to advance any portion of the catheter too far past the target site, for example, circuitous vasculature like the aortic arch. As shown in FIG. 4D, the catheter 214 may be withdrawn proximally through the deployed medical device 212.


It should be understood that the terms distal and proximal as used herein are with reference to the clinician and that other inventive embodiments contemplated may orient the catheters 14, 114 and 214 differently with respect to the vasculature, depending upon the entry point and the target site. It is also contemplated that either the distal sheath portion or proximal sheath portion, or both, could be configured so as to invert outwardly or inwardly, as described further in co-pending and co-owned application Ser. No. 12/212,620 filed on Sep. 17, 2008. By way of example, instead of the distal sheath portion 132 of FIG. 3C being moved distally with the inner tube 122 to expose the distal end 112A of medical device 112, the distal sheath portion could be inverted at a distal position and drawn into the interior of inner tube 122.


In operation, the catheters described are particularly suited for delivery of a heart valve, where precise placement is important. Other critical and less-critical target sites are also contemplated. In the case of a self-expanding aortic valve replacement, the catheter may be delivered transfemorally, transeptally, transapically or through the sub-clavian, among other possible entry ways. In one procedure, the catheter is deployed so that the valved frame is positioned entirely aligned with the target site; e.g., aortic annulus up to ascending aorta. The frame may then be exposed from one end to the other, depending upon the direction of delivery, by either advancing the inner tube relative to the central tube or vice versa, or retraction of the central shaft. As the frame is exposed, it expands outwardly to engage the native intimal lining so placement accuracy is maximized. When the sheath is fully removed and the frame fully expanded, the catheter may then be withdrawn though the functioning prosthetic valve and removed from the patient.


Although embodiments of this invention have been disclosed in the context of certain preferred embodiments and examples, it will be understood by those skilled in the art that the embodiments of the present invention extend beyond the specifically disclosed embodiments to other alternative embodiments and/or uses of the invention and obvious modifications and equivalents thereof. In particular, while the present loading system and method has been described in the context of particularly preferred embodiments, the skilled artisan will appreciate, in view of the disclosure, that certain advantages, features, and aspects of the system may be realized in a variety of other applications, many of which have been noted above. Additionally, it is contemplated that various aspects and features of the invention described can be practiced separately, combined together, or substituted for one another, and that a variety of combination and subcombinations of the features and aspects can be made and still fall within the scope of the invention. Thus, it is intended that the scope of the present invention herein disclosed should not be limited by the particular disclosed embodiments described above, but should be determined only by a fair reading of the claims.

Claims
  • 1. An apparatus for minimally invasively delivering a medical device to a target site within a patient, the apparatus comprising: a first tube having an outside surface suitable for accepting the medical device collapsed thereon in a stationary position; anda sheath including first and second portions that may be moved axially relative to each other and with respect to the first tube, the sheath portions configured so as to enclose the medical device collapsed onto the first tube when brought together, and configured to expose the medical device when directed away from each other, the first sheath portion including a proximal edge,wherein the proximal edge is elastically expandable from a first diameter to a second diameter, andwherein the proximal edge is biased radially inwardly to the first diameter when unconstrained such that the first sheath portion tapers proximally toward the first tube to reduce a profile thereof, andwherein the proximal edge is held at the second diameter by the medical device collapsed onto the first tube.
  • 2. The apparatus of claim 1, wherein the first tube includes a hub.
  • 3. The apparatus of claim 2, wherein the first sheath portion is configured so as to enclose at least a portion of the hub.
  • 4. The apparatus of claim 1, wherein either the first and/or second sheath portion is configured to invert upon itself.
  • 5. An apparatus for minimally invasively delivering a medical device to a target site within a patient, the apparatus comprising: a first tube having an outside surface suitable for accepting the medical device collapsed thereon in a stationary position, the first tube including a hub for retaining at least a portion of the medical device on the first tube,wherein the hub includes a generally extended non-tapered portion, andwherein the hub includes at least one button configured to retain the medical device on the hub until full deployment of the medical device; anda sheath including first and second portions that may be moved axially relative to each other and with respect to the first tube, the sheath portions configured so as to enclose the medical device collapsed onto the first tube when brought together, and configured to expose the medical device when directed away from each other,wherein the first sheath portion includes an elastically expandable proximal edge that is biased radially inwardly against the medical device collapsed onto the first tube when the sheath portions enclose the medical device, andwherein, during operation, when the first sheath portion is moved in a direction sufficient to expose the medical device the elastically expandable proximal edge is biased radially inwardly against the extended non-tapered portion of the hub and tapers proximally toward the first tube to maintain a low profile.
  • 6. An apparatus for delivering a medical device to a target site within a patient via a body lumen, the apparatus comprising: an inner tube;a distal sheath portion attached to the inner tube;an intermediate tube, moveable over the inner tube and at least partially into the distal sheath portion;an outer tube, moveable over the intermediate tube;a proximal sheath portion attached to the outer tube, so that, in use, the proximal sheath portion and the distal sheath portion can be moved together to substantially cover the medical device mounted on the intermediate tube and moved apart to deploy the medical device;the distal sheath portion having an elastic proximal edge biased radially inwardly to a first diameter when unconstrained such that the distal sheath portion tapers proximally toward the inner tube to reduce a profile thereof and the distal sheath portion being configured to expand from the first diameter to a second diameter to cover the medical device.
  • 7. The apparatus for delivering a medical device of claim 6, wherein the proximal edge is tapered inwardly.
  • 8. The apparatus for delivering a medical device of claim 6, wherein the proximal edge is pleated.
  • 9. The apparatus for delivering a medical device of claim 6, wherein the proximal edge is beveled.
  • 10. An apparatus for delivering a medical device to a target site within a patient via a body lumen, the apparatus comprising: an inner tube;a distal sheath portion attached to the inner tube,wherein the distal sheath portion includes an elastic proximal edge biased radially inwardly to a first diameter when unconstrained such that the distal sheath portion tapers proximally toward the inner tube to reduce a profile thereof and the elastic proximal edge being expandable from the first diameter to a second diameter to cover the medical device;an intermediate tube, moveable over the inner tube and at least partially into the distal sheath portion, the intermediate tube having a hub at its distal end and having a region on the intermediate tube proximal of the hub for mounting the medical device,wherein the region for mounting the medical device includes at least one button configured to retain the medical device on the hub until full deployment of the medical device;an outer tube, moveable over the intermediate tube; anda proximal sheath portion attached to the outer tube, so that, in use, the proximal sheath portion and the distal sheath portion can be moved together to substantially cover the medical device mounted on the intermediate tube and moved apart to deploy the medical device;the hub having an axial length sufficient to permit the medical device to be deployed while the distal sheath portion covers at least part of the hub.
  • 11. The apparatus for delivering a medical device of claim 10, wherein the hub comprises a substantially cylindrical outer surface over which the distal sheath portion can reside until the medical device is deployed.
US Referenced Citations (621)
Number Name Date Kind
3334629 Cohn Aug 1967 A
3409013 Berry Nov 1968 A
3540431 Mobin-Uddin Nov 1970 A
3587115 Shiley Jun 1971 A
3628535 Ostrowsky et al. Dec 1971 A
3642004 Osthagen et al. Feb 1972 A
3657744 Ersek Apr 1972 A
3671979 Moulopoulos Jun 1972 A
3714671 Edwards et al. Feb 1973 A
3755823 Hancock Sep 1973 A
3795246 Sturgeon Mar 1974 A
3839741 Haller Oct 1974 A
3868956 Alfidi et al. Mar 1975 A
3874388 King et al. Apr 1975 A
4035849 Angell et al. Jul 1977 A
4056854 Boretos et al. Nov 1977 A
4106129 Carpentier et al. Aug 1978 A
4222126 Boretos et al. Sep 1980 A
4233690 Akins Nov 1980 A
4265694 Boretos May 1981 A
4291420 Reul Sep 1981 A
4297749 Davis et al. Nov 1981 A
4339831 Johnson Jul 1982 A
4343048 Ross et al. Aug 1982 A
4345340 Rosen Aug 1982 A
4425908 Simon Jan 1984 A
4470157 Love Sep 1984 A
4501030 Lane Feb 1985 A
4574803 Storz Mar 1986 A
4580568 Gianturco Apr 1986 A
4592340 Boyles Jun 1986 A
4610688 Silvestrini et al. Sep 1986 A
4612011 Kautzky Sep 1986 A
4647283 Carpentier et al. Mar 1987 A
4648881 Carpentier et al. Mar 1987 A
4655771 Wallsten Apr 1987 A
4662885 DiPisa, Jr. May 1987 A
4665906 Jervis May 1987 A
4681908 Broderick et al. Jul 1987 A
4710192 Liotta et al. Dec 1987 A
4733665 Palmaz Mar 1988 A
4777951 Cribier et al. Oct 1988 A
4787899 Lazarus Nov 1988 A
4796629 Grayzel Jan 1989 A
4797901 Goerne et al. Jan 1989 A
4819751 Shimada et al. Apr 1989 A
4834755 Silvestrini et al. May 1989 A
4856516 Hillstead Aug 1989 A
4872874 Taheri Oct 1989 A
4878495 Grayzel Nov 1989 A
4878906 Lindemann et al. Nov 1989 A
4883458 Shiber Nov 1989 A
4909252 Goldberger Mar 1990 A
4917102 Miller et al. Apr 1990 A
4922905 Strecker May 1990 A
4954126 Wallsten Sep 1990 A
4966604 Reiss Oct 1990 A
4979939 Shiber Dec 1990 A
4986830 Owens et al. Jan 1991 A
4994077 Dobben Feb 1991 A
5002559 Tower Mar 1991 A
5007896 Shiber Apr 1991 A
5026366 Leckrone Jun 1991 A
5032128 Alonso Jul 1991 A
5037434 Lane Aug 1991 A
5047041 Samuels Sep 1991 A
5059177 Towne et al. Oct 1991 A
5061273 Yock Oct 1991 A
5085635 Cragg Feb 1992 A
5089015 Ross Feb 1992 A
5152771 Sabbaghian et al. Oct 1992 A
5161547 Tower Nov 1992 A
5163953 Vince Nov 1992 A
5167628 Boyles Dec 1992 A
5217483 Tower Jun 1993 A
5232445 Bonzel Aug 1993 A
5272909 Nguyen et al. Dec 1993 A
5295958 Shturman Mar 1994 A
5327774 Nguyen et al. Jul 1994 A
5332402 Teitelbaum et al. Jul 1994 A
5350398 Pavcnik et al. Sep 1994 A
5370685 Stevens Dec 1994 A
5389106 Tower Feb 1995 A
5397351 Pavcnik et al. Mar 1995 A
5411552 Andersen et al. May 1995 A
5415633 Lazarus et al. May 1995 A
5431676 Dubrul et al. Jul 1995 A
5443446 Shturman Aug 1995 A
5449384 Johnson Sep 1995 A
5480424 Cox Jan 1996 A
5489294 McVenes et al. Feb 1996 A
5489297 Duran Feb 1996 A
5496346 Horzewski et al. Mar 1996 A
5500014 Quijano et al. Mar 1996 A
5507767 Maeda et al. Apr 1996 A
5534007 St. Germain et al. Jul 1996 A
5545209 Roberts et al. Aug 1996 A
5545211 An et al. Aug 1996 A
5545214 Stevens Aug 1996 A
5554185 Block et al. Sep 1996 A
5575818 Pinchuk Nov 1996 A
5580922 Park et al. Dec 1996 A
5591195 Taheri et al. Jan 1997 A
5609626 Quijano et al. Mar 1997 A
5645559 Hachtman et al. Jul 1997 A
5665115 Cragg Sep 1997 A
5667523 Bynon et al. Sep 1997 A
5674277 Freitag Oct 1997 A
5695498 Tower Dec 1997 A
5702368 Stevens et al. Dec 1997 A
5713953 Vallana et al. Feb 1998 A
5716417 Girard et al. Feb 1998 A
5746709 Rom et al. May 1998 A
5749890 Shaknovich May 1998 A
5766151 Valley et al. Jun 1998 A
5782809 Umeno et al. Jul 1998 A
5800456 Maeda et al. Sep 1998 A
5800508 Goicoechea et al. Sep 1998 A
5817126 Imran Oct 1998 A
5824041 Lenker Oct 1998 A
5824043 Cottone, Jr. Oct 1998 A
5824053 Khosravi et al. Oct 1998 A
5824056 Rosenberg Oct 1998 A
5824061 Quijano et al. Oct 1998 A
5824064 Taheri Oct 1998 A
5840081 Andersen et al. Nov 1998 A
5843158 Lenker et al. Dec 1998 A
5851232 Lois Dec 1998 A
5855597 Jayaraman Jan 1999 A
5855601 Bessler et al. Jan 1999 A
5860966 Tower Jan 1999 A
5861028 Angell Jan 1999 A
5868783 Tower Feb 1999 A
5876448 Thompson et al. Mar 1999 A
5888201 Stinson et al. Mar 1999 A
5891191 Stinson Apr 1999 A
5906619 Olson et al. May 1999 A
5907893 Zadno-Azizi et al. Jun 1999 A
5913842 Boyd et al. Jun 1999 A
5925063 Khosravi Jul 1999 A
5944738 Amplatz et al. Aug 1999 A
5954766 Zadno-Azizi et al. Sep 1999 A
5957949 Leonhardt et al. Sep 1999 A
5968068 Dehdashtian et al. Oct 1999 A
5984957 Laptewicz, Jr. et al. Nov 1999 A
5989280 Euteneuer et al. Nov 1999 A
5997573 Quijano et al. Dec 1999 A
6022370 Tower Feb 2000 A
6027525 Suh et al. Feb 2000 A
6029671 Stevens et al. Feb 2000 A
6042589 Marianne Mar 2000 A
6042598 Tsugita et al. Mar 2000 A
6042607 Williamson, IV Mar 2000 A
6051014 Jang Apr 2000 A
6059809 Amor et al. May 2000 A
6110201 Quijano et al. Aug 2000 A
6146366 Schachar Nov 2000 A
6159239 Greenhalgh Dec 2000 A
6162208 Hipps Dec 2000 A
6162245 Jayaraman Dec 2000 A
6168614 Andersen et al. Jan 2001 B1
6171335 Wheatley et al. Jan 2001 B1
6200336 Pavcnik et al. Mar 2001 B1
6203550 Olson Mar 2001 B1
6210408 Chandrasekaran et al. Apr 2001 B1
6218662 Tchakarov et al. Apr 2001 B1
6221006 Dubrul et al. Apr 2001 B1
6221091 Khosravi Apr 2001 B1
6241757 An et al. Jun 2001 B1
6245102 Jayaraman Jun 2001 B1
6248116 Chevilon Jun 2001 B1
6258114 Konya et al. Jul 2001 B1
6258115 Dubrul Jul 2001 B1
6258120 McKenzie et al. Jul 2001 B1
6277555 Duran et al. Aug 2001 B1
6299637 Shaolia et al. Oct 2001 B1
6302906 Goicoechea et al. Oct 2001 B1
6309382 Garrison et al. Oct 2001 B1
6309417 Spence et al. Oct 2001 B1
6327772 Zadno-Azizi et al. Dec 2001 B1
6338735 Stevens Jan 2002 B1
6348063 Yassour et al. Feb 2002 B1
6350277 Kocur Feb 2002 B1
6352708 Duran et al. Mar 2002 B1
6371970 Khosravi et al. Apr 2002 B1
6371983 Lane Apr 2002 B1
6379383 Palmaz et al. Apr 2002 B1
6380457 Yurek et al. Apr 2002 B1
6398807 Chouinard et al. Jun 2002 B1
6409750 Hyodoh et al. Jun 2002 B1
6416536 Yee Jul 2002 B1
6425916 Garrison et al. Jul 2002 B1
6440164 DiMatteo et al. Aug 2002 B1
6454799 Schreck Sep 2002 B1
6458153 Bailey et al. Oct 2002 B1
6461382 Cao Oct 2002 B1
6468303 Amplatz et al. Oct 2002 B1
6475239 Campbell et al. Nov 2002 B1
6482228 Norred Nov 2002 B1
6488704 Connelly et al. Dec 2002 B1
6494909 Greenhalgh Dec 2002 B2
6503272 Duerig et al. Jan 2003 B2
6508833 Pavcnik et al. Jan 2003 B2
6527800 McGuckin, Jr. et al. Mar 2003 B1
6530947 Euteneuer et al. Mar 2003 B1
6530949 Konya et al. Mar 2003 B2
6530952 Vesely Mar 2003 B2
6562031 Chandrasekaran et al. May 2003 B2
6562058 Seguin et al. May 2003 B2
6569196 Vesely May 2003 B1
6585758 Chouinard et al. Jul 2003 B1
6592546 Barbut et al. Jul 2003 B1
6605112 Moll et al. Aug 2003 B1
6613077 Gilligan et al. Sep 2003 B2
6622604 Chouinard et al. Sep 2003 B1
6632243 Zadno-Azizi et al. Oct 2003 B1
6635068 Dubrul et al. Oct 2003 B1
6645240 Yee Nov 2003 B2
6652571 White et al. Nov 2003 B1
6652578 Bailey et al. Nov 2003 B2
6656213 Solem Dec 2003 B2
6663663 Kim et al. Dec 2003 B2
6669724 Park et al. Dec 2003 B2
6673089 Yassour et al. Jan 2004 B1
6673109 Cox Jan 2004 B2
6676698 McGuckin, Jr. et al. Jan 2004 B2
6682558 Tu et al. Jan 2004 B2
6682559 Myers et al. Jan 2004 B2
6685739 DiMatteo et al. Feb 2004 B2
6689144 Gerberding Feb 2004 B2
6689164 Seguin Feb 2004 B1
6692512 Jang Feb 2004 B2
6692513 Streeter et al. Feb 2004 B2
6695878 McGuckin, Jr. et al. Feb 2004 B2
6702851 Chinn et al. Mar 2004 B1
6719789 Cox Apr 2004 B2
6730118 Spenser et al. May 2004 B2
6730377 Wang May 2004 B2
6733525 Yang et al. May 2004 B2
6736846 Cox May 2004 B2
6752828 Thornton Jun 2004 B2
6758855 Fulton, III et al. Jul 2004 B2
6769434 Liddicoat et al. Aug 2004 B2
6786925 Schoon et al. Sep 2004 B1
6790229 Berreklouw Sep 2004 B1
6792979 Konya et al. Sep 2004 B2
6797002 Spence Sep 2004 B2
6821297 Snyders Nov 2004 B2
6830575 Stenzel et al. Dec 2004 B2
6830584 Seguin Dec 2004 B1
6830585 Artof Dec 2004 B1
6846325 Liddicoat Jan 2005 B2
6866650 Stevens Mar 2005 B2
6872223 Roberts Mar 2005 B2
6875231 Anduiza et al. Apr 2005 B2
6883522 Spence et al. Apr 2005 B2
6887266 Williams et al. May 2005 B2
6890330 Streeter et al. May 2005 B2
6893460 Spenser et al. May 2005 B2
6896690 Lambrecht et al. May 2005 B1
6908481 Cribier Jun 2005 B2
6913600 Valley et al. Jul 2005 B2
6929653 Strecter Aug 2005 B2
6936066 Palmaz et al. Aug 2005 B2
6939365 Fogarty et al. Sep 2005 B1
6951571 Srivastava Oct 2005 B1
6974474 Pavcnik et al. Dec 2005 B2
6974476 McGuckin et al. Dec 2005 B2
6986742 Hart et al. Jan 2006 B2
6989027 Allen et al. Jan 2006 B2
6989028 Lashinski et al. Jan 2006 B2
6991649 Sievers Jan 2006 B2
7004964 Thompson et al. Feb 2006 B2
7018401 Hyodoh et al. Mar 2006 B1
7022133 Yee et al. Apr 2006 B2
7041128 McGuckin, Jr. et al. May 2006 B2
7044966 Svanidze et al. May 2006 B2
7048014 Hyodoh et al. May 2006 B2
7097659 Woolfson et al. Aug 2006 B2
7101396 Artof et al. Sep 2006 B2
7105016 Shui et al. Sep 2006 B2
7115141 Menz et al. Oct 2006 B2
7128759 Osborne et al. Oct 2006 B2
7147663 Berg et al. Dec 2006 B1
7153324 Case et al. Dec 2006 B2
7160319 Chouinard et al. Jan 2007 B2
7175656 Khairkhahan Feb 2007 B2
7186265 Sharkawy et al. Mar 2007 B2
7195641 Palmaz et al. Mar 2007 B2
7198646 Figulla et al. Apr 2007 B2
7201761 Woolfson et al. Apr 2007 B2
7201772 Schwammenthal et al. Apr 2007 B2
7252682 Seguin Aug 2007 B2
7300457 Palmaz Nov 2007 B2
7300463 Liddicoat Nov 2007 B2
7316706 Bloom et al. Jan 2008 B2
7320703 DiMatteo et al. Jan 2008 B2
7329278 Seguin Feb 2008 B2
7335218 Wilson et al. Feb 2008 B2
7338520 Bailey et al. Mar 2008 B2
7374571 Pease et al. May 2008 B2
7377938 Sarac et al. May 2008 B2
7381218 Schreck Jun 2008 B2
7384411 Condado Jun 2008 B1
7429269 Schwammenthal et al. Sep 2008 B2
7442204 Schwammenthal et al. Oct 2008 B2
7462191 Spenser et al. Dec 2008 B2
7470284 Lambrecht et al. Dec 2008 B2
7481838 Carpentier et al. Jan 2009 B2
7544206 Cohn et al. Jun 2009 B2
7547322 Sarac et al. Jun 2009 B2
7556646 Yang et al. Jul 2009 B2
20010001314 Davison et al. May 2001 A1
20010002445 Vesely May 2001 A1
20010007956 Letac et al. Jul 2001 A1
20010010017 Letac et al. Jul 2001 A1
20010011189 Drasler et al. Aug 2001 A1
20010021872 Bailey et al. Sep 2001 A1
20010025196 Chinn et al. Sep 2001 A1
20010032013 Marton Oct 2001 A1
20010039450 Pavcnik et al. Nov 2001 A1
20010041928 Pavcnik et al. Nov 2001 A1
20010044647 Pinchuk et al. Nov 2001 A1
20020010508 Chobotov Jan 2002 A1
20020029014 Jayaraman Mar 2002 A1
20020032480 Spence et al. Mar 2002 A1
20020032481 Gabbay Mar 2002 A1
20020035396 Heath Mar 2002 A1
20020042650 Vardi et al. Apr 2002 A1
20020052651 Myers et al. May 2002 A1
20020058995 Stevens May 2002 A1
20020072789 Hackett et al. Jun 2002 A1
20020077696 Zadno-Azizi et al. Jun 2002 A1
20020095209 Zadno-Azizi et al. Jul 2002 A1
20020099439 Schwartz et al. Jul 2002 A1
20020103533 Langberg et al. Aug 2002 A1
20020107565 Greenhalgh Aug 2002 A1
20020111674 Chouinard et al. Aug 2002 A1
20020123802 Snyders Sep 2002 A1
20020133183 Lentz et al. Sep 2002 A1
20020138138 Yang Sep 2002 A1
20020151970 Garrison et al. Oct 2002 A1
20020161392 Dubrul Oct 2002 A1
20020161394 Macoviak et al. Oct 2002 A1
20020193871 Beyersdorf et al. Dec 2002 A1
20030014104 Cribier Jan 2003 A1
20030023300 Bailey et al. Jan 2003 A1
20030023303 Palmaz et al. Jan 2003 A1
20030028247 Cali Feb 2003 A1
20030036791 Philipp et al. Feb 2003 A1
20030040771 Hyodoh et al. Feb 2003 A1
20030040772 Hyodoh et al. Feb 2003 A1
20030040792 Gabbay Feb 2003 A1
20030050694 Yang et al. Mar 2003 A1
20030055495 Pease et al. Mar 2003 A1
20030065386 Weadock Apr 2003 A1
20030069492 Abrams et al. Apr 2003 A1
20030109924 Cribier Jun 2003 A1
20030125795 Pavcnik et al. Jul 2003 A1
20030130726 Thorpe et al. Jul 2003 A1
20030130729 Paniagua et al. Jul 2003 A1
20030139804 Hankh et al. Jul 2003 A1
20030149475 Hyodoh et al. Aug 2003 A1
20030149476 Damm et al. Aug 2003 A1
20030149478 Figulla et al. Aug 2003 A1
20030153974 Spenser et al. Aug 2003 A1
20030163189 Thompson et al. Aug 2003 A1
20030181850 Diamond et al. Sep 2003 A1
20030191519 Lombardi et al. Oct 2003 A1
20030199913 Dubrul et al. Oct 2003 A1
20030199963 Tower et al. Oct 2003 A1
20030199971 Tower et al. Oct 2003 A1
20030199972 Zadno-Azizi et al. Oct 2003 A1
20030212410 Stenzel et al. Nov 2003 A1
20030212452 Zadno-Azizi et al. Nov 2003 A1
20030212454 Scott et al. Nov 2003 A1
20030225445 Derus et al. Dec 2003 A1
20040019374 Hojeibane et al. Jan 2004 A1
20040034411 Quijano et al. Feb 2004 A1
20040039436 Spenser et al. Feb 2004 A1
20040049224 Buehlmann et al. Mar 2004 A1
20040049262 Obermiller et al. Mar 2004 A1
20040049266 Anduiza et al. Mar 2004 A1
20040082904 Houde et al. Apr 2004 A1
20040088045 Cox May 2004 A1
20040092858 Wilson et al. May 2004 A1
20040092989 Wilson et al. May 2004 A1
20040093005 Durcan May 2004 A1
20040093060 Seguin et al. May 2004 A1
20040093075 Kuehne May 2004 A1
20040097788 Mourlas et al. May 2004 A1
20040098112 DiMatteo et al. May 2004 A1
20040106976 Bailey et al. Jun 2004 A1
20040106990 Spence et al. Jun 2004 A1
20040111096 Tu et al. Jun 2004 A1
20040116951 Rosengart Jun 2004 A1
20040117004 Osborne et al. Jun 2004 A1
20040122468 Yodfat et al. Jun 2004 A1
20040122514 Fogarty et al. Jun 2004 A1
20040122516 Fogarty Jun 2004 A1
20040127979 Wilson Jul 2004 A1
20040138742 Myers et al. Jul 2004 A1
20040138743 Myers et al. Jul 2004 A1
20040153146 Lashinski et al. Aug 2004 A1
20040167573 Williamson Aug 2004 A1
20040167620 Ortiz Aug 2004 A1
20040186563 Iobbi Sep 2004 A1
20040193261 Berreklouw Sep 2004 A1
20040210240 Saint Oct 2004 A1
20040210304 Seguin et al. Oct 2004 A1
20040210307 Khairkhahan Oct 2004 A1
20040215333 Duran Oct 2004 A1
20040215339 Drasler et al. Oct 2004 A1
20040225353 McGuckin, Jr. Nov 2004 A1
20040225354 Allen Nov 2004 A1
20040254636 Flagle et al. Dec 2004 A1
20040260389 Case et al. Dec 2004 A1
20040260394 Douk et al. Dec 2004 A1
20040267357 Allen et al. Dec 2004 A1
20050010246 Streeter Jan 2005 A1
20050010285 Lambrecht et al. Jan 2005 A1
20050010287 Macoviak Jan 2005 A1
20050015112 Cohn et al. Jan 2005 A1
20050027348 Case et al. Feb 2005 A1
20050033398 Seguin Feb 2005 A1
20050038495 Greenan Feb 2005 A1
20050043790 Seguin Feb 2005 A1
20050049692 Numamoto Mar 2005 A1
20050049696 Siess Mar 2005 A1
20050055088 Liddicoat et al. Mar 2005 A1
20050060029 Le Mar 2005 A1
20050060030 Lashinski et al. Mar 2005 A1
20050075584 Cali Apr 2005 A1
20050075712 Biancucci Apr 2005 A1
20050075717 Nguyen Apr 2005 A1
20050075719 Bergheim Apr 2005 A1
20050075724 Svanidze Apr 2005 A1
20050075727 Wheatley Apr 2005 A1
20050075730 Myers Apr 2005 A1
20050075731 Artof Apr 2005 A1
20050080474 Andreas et al. Apr 2005 A1
20050085841 Eversull et al. Apr 2005 A1
20050085842 Eversull et al. Apr 2005 A1
20050085843 Opolski et al. Apr 2005 A1
20050085890 Rasmussen et al. Apr 2005 A1
20050085900 Case et al. Apr 2005 A1
20050096568 Kato May 2005 A1
20050096692 Linder et al. May 2005 A1
20050096724 Stenzel et al. May 2005 A1
20050096734 Majercak et al. May 2005 A1
20050096735 Hojeibane et al. May 2005 A1
20050096736 Osse et al. May 2005 A1
20050096738 Cali et al. May 2005 A1
20050107871 Realyvasquez et al. May 2005 A1
20050113910 Paniagua May 2005 A1
20050119688 Bergheim Jun 2005 A1
20050131438 Cohn Jun 2005 A1
20050137686 Salahieh Jun 2005 A1
20050137688 Salahieh et al. Jun 2005 A1
20050137692 Haug Jun 2005 A1
20050137695 Salahieh Jun 2005 A1
20050137701 Salahieh Jun 2005 A1
20050143807 Pavcnik et al. Jun 2005 A1
20050143809 Salahieh Jun 2005 A1
20050148997 Valley et al. Jul 2005 A1
20050165477 Anduiza et al. Jul 2005 A1
20050187616 Realyvasquez Aug 2005 A1
20050197695 Stacchino et al. Sep 2005 A1
20050203549 Realyvasquez Sep 2005 A1
20050203605 Dolan Sep 2005 A1
20050203618 Sharkawy Sep 2005 A1
20050222674 Paine Oct 2005 A1
20050228495 Macoviak Oct 2005 A1
20050234546 Nugent Oct 2005 A1
20050240200 Bergheim Oct 2005 A1
20050240263 Fogarty et al. Oct 2005 A1
20050261759 Lambrecht et al. Nov 2005 A1
20050283962 Boudjemline Dec 2005 A1
20060004439 Spenser et al. Jan 2006 A1
20060004469 Sokel Jan 2006 A1
20060009841 McGuckin et al. Jan 2006 A1
20060052867 Revuelta et al. Mar 2006 A1
20060058775 Stevens et al. Mar 2006 A1
20060089711 Dolan Apr 2006 A1
20060100685 Seguin et al. May 2006 A1
20060116757 Lashinski et al. Jun 2006 A1
20060135964 Vesely Jun 2006 A1
20060136036 Thompson et al. Jun 2006 A1
20060142848 Gabbay Jun 2006 A1
20060167474 Bloom et al. Jul 2006 A1
20060178740 Stacchino et al. Aug 2006 A1
20060195134 Crittenden Aug 2006 A1
20060206192 Tower et al. Sep 2006 A1
20060206202 Bonhoefer et al. Sep 2006 A1
20060212111 Case et al. Sep 2006 A1
20060247763 Slater Nov 2006 A1
20060259134 Schwammenthal et al. Nov 2006 A1
20060259136 Nguyen et al. Nov 2006 A1
20060259137 Artof et al. Nov 2006 A1
20060265056 Nguyen et al. Nov 2006 A1
20060271166 Thill et al. Nov 2006 A1
20060271175 Woolfson et al. Nov 2006 A1
20060276874 Wilson et al. Dec 2006 A1
20060276882 Case et al. Dec 2006 A1
20060282161 Huynh et al. Dec 2006 A1
20070005129 Damm et al. Jan 2007 A1
20070005131 Taylor Jan 2007 A1
20070010878 Raffiee et al. Jan 2007 A1
20070016286 Herrmann et al. Jan 2007 A1
20070027518 Case et al. Feb 2007 A1
20070027533 Douk Feb 2007 A1
20070038295 Case et al. Feb 2007 A1
20070043381 Furst et al. Feb 2007 A1
20070043431 Melsheimer Feb 2007 A1
20070043435 Seguin et al. Feb 2007 A1
20070051377 Douk et al. Mar 2007 A1
20070073392 Heyninck-Janitz Mar 2007 A1
20070078509 Lotfy et al. Apr 2007 A1
20070078510 Ryan Apr 2007 A1
20070088431 Bourang et al. Apr 2007 A1
20070093869 Bloom et al. Apr 2007 A1
20070100439 Cangialosi May 2007 A1
20070100440 Figulla May 2007 A1
20070100449 O'Neil et al. May 2007 A1
20070112415 Bartlett May 2007 A1
20070162102 Ryan et al. Jul 2007 A1
20070162113 Sharkawy et al. Jul 2007 A1
20070185513 Woolfson et al. Aug 2007 A1
20070203391 Bloom et al. Aug 2007 A1
20070225681 House Sep 2007 A1
20070232898 Huynh et al. Oct 2007 A1
20070233222 Roeder et al. Oct 2007 A1
20070233228 Eberhardt et al. Oct 2007 A1
20070233237 Krivoruchko Oct 2007 A1
20070233238 Huynh et al. Oct 2007 A1
20070238979 Huynh et al. Oct 2007 A1
20070239254 Marchand et al. Oct 2007 A1
20070239265 Birdsall Oct 2007 A1
20070239266 Birdsall Oct 2007 A1
20070239269 Dolan et al. Oct 2007 A1
20070239273 Allen Oct 2007 A1
20070244544 Birdsall et al. Oct 2007 A1
20070244545 Birdsall et al. Oct 2007 A1
20070244546 Francis Oct 2007 A1
20070244553 Rafiee et al. Oct 2007 A1
20070244554 Rafiee et al. Oct 2007 A1
20070244555 Rafiee et al. Oct 2007 A1
20070244556 Rafiee et al. Oct 2007 A1
20070244557 Rafiee et al. Oct 2007 A1
20070250160 Rafiee Oct 2007 A1
20070255394 Ryan Nov 2007 A1
20070255396 Douk et al. Nov 2007 A1
20070288000 Bonan Dec 2007 A1
20080004696 Vesely Jan 2008 A1
20080009940 Cribier Jan 2008 A1
20080015671 Bonhoeffer Jan 2008 A1
20080021552 Gabbay Jan 2008 A1
20080048656 Tan Feb 2008 A1
20080065011 Marchand et al. Mar 2008 A1
20080065206 Liddicoat Mar 2008 A1
20080071361 Tuval et al. Mar 2008 A1
20080071362 Tuval et al. Mar 2008 A1
20080071363 Tuval et al. Mar 2008 A1
20080071366 Tuval et al. Mar 2008 A1
20080071368 Tuval et al. Mar 2008 A1
20080077234 Styrc Mar 2008 A1
20080082165 Wilson et al. Apr 2008 A1
20080082166 Styrc et al. Apr 2008 A1
20080133003 Seguin et al. Jun 2008 A1
20080140189 Nguyen et al. Jun 2008 A1
20080147105 Wilson et al. Jun 2008 A1
20080147180 Ghione et al. Jun 2008 A1
20080147181 Ghione et al. Jun 2008 A1
20080147182 Righini et al. Jun 2008 A1
20080154355 Benichow et al. Jun 2008 A1
20080154356 Obermiller et al. Jun 2008 A1
20080161910 Revuelta et al. Jul 2008 A1
20080161911 Revuelta et al. Jul 2008 A1
20080183273 Mesana et al. Jul 2008 A1
20080188928 Salahieh et al. Aug 2008 A1
20080215143 Seguin et al. Sep 2008 A1
20080215144 Ryan et al. Sep 2008 A1
20080228254 Ryan Sep 2008 A1
20080228263 Ryan Sep 2008 A1
20080234797 Styrc Sep 2008 A1
20080243246 Ryan et al. Oct 2008 A1
20080255651 Dwork Oct 2008 A1
20080255660 Guyenot et al. Oct 2008 A1
20080255661 Straubinger et al. Oct 2008 A1
20080262593 Ryan et al. Oct 2008 A1
20080269878 Iobbi Oct 2008 A1
20090005863 Goetz et al. Jan 2009 A1
20090012600 Styrc et al. Jan 2009 A1
20090048656 Wen Feb 2009 A1
20090054976 Tuval et al. Feb 2009 A1
20090069886 Suri et al. Mar 2009 A1
20090069887 Righini et al. Mar 2009 A1
20090069889 Suri et al. Mar 2009 A1
20090085900 Weiner Apr 2009 A1
20090099653 Suri et al. Apr 2009 A1
20090138079 Tuval et al. May 2009 A1
20090164004 Cohn Jun 2009 A1
20090171447 VonSeggesser et al. Jul 2009 A1
20090192585 Bloom et al. Jul 2009 A1
20090192586 Tabor et al. Jul 2009 A1
20090192591 Ryan et al. Jul 2009 A1
20090198316 Laske et al. Aug 2009 A1
20090216310 Straubinger et al. Aug 2009 A1
20090216312 Straubinger et al. Aug 2009 A1
20090216313 Straubinger et al. Aug 2009 A1
20090234443 Ottma et al. Sep 2009 A1
20090240264 Tuval et al. Sep 2009 A1
20090240320 Tuval Sep 2009 A1
20090287296 Manasse Nov 2009 A1
20100036479 Hill et al. Feb 2010 A1
20100094411 Tuval et al. Apr 2010 A1
20100100167 Bortlein et al. Apr 2010 A1
20100131054 Tuval et al. May 2010 A1
20100137979 Tuval et al. Jun 2010 A1
20100161045 Righini Jun 2010 A1
20100234940 Dolan Sep 2010 A1
Foreign Referenced Citations (67)
Number Date Country
2007-10007443.3 Aug 2007 CN
3640745 Jun 1987 DE
195 46 692 Jun 1997 DE
195 46 692 Jun 1997 DE
198 57 887 Jul 2000 DE
0103546 Mar 1984 EP
0597967 Dec 1994 EP
0850607 Jul 1998 EP
1057459 Jun 2000 EP
1057460 Jun 2000 EP
1088529 Apr 2001 EP
1255510 Nov 2002 EP
0937439 Sep 2003 EP
1340473 Sep 2003 EP
0819013 Jun 2004 EP
1469797 Nov 2005 EP
2788217 Dec 1999 FR
2815844 May 2000 FR
2056023 Mar 1981 GB
2433700 Dec 2007 GB
9117720 Nov 1991 WO
9301768 Feb 1993 WO
9529640 Nov 1995 WO
9814137 Apr 1998 WO
9829057 Jul 1998 WO
9933414 Jul 1999 WO
0041652 Jul 2000 WO
0044313 Aug 2000 WO
0047136 Aug 2000 WO
0047139 Aug 2000 WO
2009111241 Sep 2000 WO
0135870 May 2001 WO
0149213 Jul 2001 WO
0154625 Aug 2001 WO
0162189 Aug 2001 WO
0164137 Sep 2001 WO
0176510 Oct 2001 WO
0222054 Mar 2002 WO
0236048 May 2002 WO
0241789 May 2002 WO
0243620 Jun 2002 WO
0247575 Jun 2002 WO
0249540 Jun 2002 WO
03003943 Jan 2003 WO
03003949 Jan 2003 WO
03011195 Feb 2003 WO
03030776 Apr 2003 WO
2004019811 Mar 2004 WO
2004019825 Mar 2004 WO
2004023980 Mar 2004 WO
2004041126 May 2004 WO
2004058106 Jul 2004 WO
2004089250 Oct 2004 WO
2005004753 Jan 2005 WO
2005027790 Mar 2005 WO
2005046528 May 2005 WO
2006026371 Mar 2006 WO
2008047354 Apr 2008 WO
2008100599 Aug 2008 WO
2008138584 Nov 2008 WO
2008150529 Dec 2008 WO
2009002548 Dec 2008 WO
2009029199 Mar 2009 WO
2009042196 Apr 2009 WO
2009045338 Apr 2009 WO
2009061389 May 2009 WO
2009091509 Jul 2009 WO
Non-Patent Literature Citations (80)
Entry
U.S. Appl. No. 12/250,163, filed Oct. 13, 2008.
U.S. Appl. No. 61/192,199, filed Sep. 15, 2008.
U.S. Appl. No. 12/253,858, filed Oct. 17, 2008.
U.S. Appl. No. 12/596,343, filed Apr. 14, 2008.
U.S. Appl. No. 61/129,170, filed Jun. 9, 2008.
Andersen, H.R. et al, “Transluminal implantation of artificial heart valves. Description of a new expandable aortic valve and initial results with implantation by catheter technique in closed chest pigs.” Euro. Heart J. (1992) 13:704-708.
Babaliaros, et al., “State of the Art Percutaneous Intervention for the Treatment of Valvular Heart Disease: A Review of the Current Technologies and Ongoing Research in the Field of Percutaneous Heart Valve Replacement and Repair,” Cardiology 2007; 107:87-96.
Bailey, “Percutaneous Expandable Prosthetic Valves,” In: Topol EJ, ed. Textbook of Interventional Cardiology. vol. II. Second edition. WB Saunders, Philadelphia, 1994:1268-1276.
Block, et al., “Percutaneous Approaches to Valvular Heart Disease,” Current Cardiology Reports, vol. 7 (2005) pp. 108-113.
Bonhoeffer, et al, “Percutaneous Insertion of the Pulmonary Valve,” Journal of the American College of Cardiology (United States), May 15, 2002, pp. 1664-1669.
Bonhoeffer, et al, “Percutaneous Mitral Valve Dilatation with the Multi-Track System,” Catheterization and Cardiovascular Interventions—Official Journal of the Society for Cardiac Angiography & Interventions (United States), Oct. 1999, pp. 178-183.
Bonhoeffer, et al, “Percutaneous Replacement of Pulmonary Valve in a Right-Ventricle to Pulmonary-Artery Prosthetic Conduit with Valve Dysfunction,” Lancet (England), Oct. 21, 2000, pp. 1403-1405.
Bonhoeffer, et al, “Technique and Results of Percutaneous Mitral Valvuloplasty With the Multi-Track System,” Journal of Interventional Cardiology (United States), 200, pp. 263-268.
Bonhoeffer, et al, “Transcatheter Implantation of a Bovine Valve in Pulmonary Position: A Lamb Study,” Circulation (United States), Aug. 15, 2000, pp. 813-816.
Boudjemline, et al, “Images in Cardiovascular Medicine. Percutaneous Aortic Valve Replacement in Animals,” Circulation (United States), Mar. 16, 2004, 109, p. e161.
Boudjemline, et al, “Is Percutaneous Implantation of a Bovine Venous Valve in the Inferior Vena Cava a Reliable Technique to Treat Chronic Venous Insufficiency Syndrome?” Medical Science Monitor—International Medical Journal of Experimental and Clinical Research (Poland), Mar. 2004, pp. BR61-BR66.
Boudjemline, et al, “Off-pump Replacement of the Pulmonary Valve in Large Right Ventricular Outflow Tracts: A Hybrid Approach,” Journal of Thoracic and Cardiovascular Surgery (United States), Apr. 2005, pp. 831-837.
Boudjemline, et al, “Percutaneous Aortic Valve Replacement: Will We Get There?” Heart (British Cardiac Society) (England), Dec. 2001, pp. 705-706.
Boudjemline, et al, “Percutaneous Closure of a Paravalvular Mitral Regurgitation with Amplatzer and Coil Prostheses,” Archives des Maladies du Coeur Et Des Vaisseaux (France), May 2002, pp. 483-486.
Boudjemline, et al, “Percutaneous Implantation of a Biological Valve in the Aorta to Treat Aortic Valve Insufficiency—A Sheep Study,” Medical Science Monitor—International Medical Journal of Experimental and Clinical Research (Poland), Apr. 2002, pp. BR113-BR116.
Boudjemline, et al, “Percutaneous Implantation of a Biological Valve in Aortic Position: Preliminary Results in a Sheep Study,” European Heart Journal 22, Sep. 2001, p. 630.
Boudjemline, et al, “Percutaneous Implantation of a Valve in the Descending Aorta in Lambs,” European Heart Journal (England), Jul. 2002, pp. 1045-1049.
Boudjemline, et al, “Percutaneous Pulmonary Valve Replacement in a Large Right Ventricular Outflow Tract: An Experimental Study,” Journal of the American College of Cardiology (United States), Mar. 17, 2004; pp. 1082-1087.
Boudjemline, et al, “Percutaneous Valve Insertion: A New Approach,” Journal of Thoracic and Cardiovascular Surgery (United States), Mar. 2003, pp. 741-742.
Boudjemline, et al, “Stent Implantation Combined with a Valve Replacement to Treat Degenerated Right Ventricle to Pulmonary Artery Prosthetic Conduits,” European Heart Journal 22, Sep. 2001, p. 355.
Boudjemline, et al, “Steps Toward Percutaneous Aortic Valve Replacement,” Circulation (United States), Feb. 12, 2002, pp. 775-778.
Boudjemline, et al, “The Percutaneous Implantable Heart Valve,” Progress in Pediatric Cardiology (Ireland), 2001, pp. 89-93.
Boudjemline, et al, “Transcatheter Reconstruction of the Right Heart,” Cardiology in the Young (England), Jun. 2003, pp. 308-311.
Coats, et al, “The Potential Impact of Percutaneous Pulmonary Valve Stent Implantation on Right Ventricular Outflow Tract Re-Intervention,” European Journal of Cardio-Thoracic Surgery (England), Apr. 2005, pp. 536-543.
Cribier, A. et al, “Percutaneous Transcatheter Implantation of an Aortic Valve Prosthesis for Calcific Aortic Stenosis: First Human Case Description,” Circulation (2002) 3006-3008.
Davidson et al., “Percutaneous therapies for valvular heart disease,” Cardiovascular Pathology 15 (2006) 123-129.
Hanzel, et al., “Complications of percutaneous aortic valve replacement: experience with the Criber-Edwards™ percutaneous heart valve,” EuroIntervention Supplements (2006), 1 (Supplement A) A3-A8.
Huber, et al., “Do Valved Stents Compromise Coronary Flow?” Eur. J. Cardiothorac. Surg. 2004;25:754-759.
Khambadkone, “Nonsurgical Pulmonary Valve Replacement: Why, When, and How?” Catheterization and Cardiovascular Interventions—Official Journal of the Society for Cardiac Angiography & Interventions (United States), Jul. 2004, pp. 401-408.
Khambadkone, et al, “Percutaneous Implantation of Pulmonary Valves,” Expert Review of Cardiovascular Therapy (England), Nov. 2003, pp. 541-548.
Khambadkone, et al, “Percutaneous Pulmonary Valve Implantation: Early and Medium Term Results,” Circulation 108 (17 Supplement), Oct. 28, 2003, p. IV-375.
Khambadkone, et al, “Percutaneous Pulmonary Valve Implantation: Impact of Morphology on Case Selection,” Circulation 108 (17 Supplement), Oct. 28, 2003, p. IV-642-IV-643.
Lutter, et al, “Percutaneous Aortic Valve Replacement: An Experimental Study. I. Studies on Implantation,” The Journal of Thoracic and Cardiovascular Surgery, Apr. 2002, pp. 768-776.
Lutter, et al, “Percutaneous Valve Replacement: Current State and Future Prospects,” Annals of Thoracic Surgery (Netherlands), Dec. 2004, pp. 2199-2206.
Medtech Insight, “New Frontiers in Heart Valve Disease,” vol. 7, No. 8 (2005).
Palacios, “Percutaneous Valve Replacement and Repair, Fiction or Reality?” Journal of American College of Cardiology, vol. 44, No. 8 (2004) pp. 1662-1663.
Ruiz, “Transcathether Aortic Valve Implantation and Mitral Valve Repair: State of the Art,” Pediatric Cardiology, vol. 26, No. 3 (2005).
Saliba, et al, “Treatment of Obstructions of Prosthetic Conduits by Percutaneous Implantation of Stents,” Archives des Maldies du Coeur et des Vaisseaux (France), 1999, pp. 591-596.
Webb, et al., “Percutaneous Aortic Valve Implantation Retrograde from the Femoral Artery,” Circulation (2006), 113;842-850.
Yonga, et al, “Effect of Percutaneous Balloon Mitral Valvotomy on Pulmonary Venous Flow in Severe Mitral Stenosis,” East African Medical Journal (Kenya), Jan. 1999, pp. 28-30.
Yonga, et al, “Percutaneous Balloon Mitral Valvotomy: Initial Experience in Nairobi Using a New Multi-Track Catheter System,” East African Medical Journal (Kenya), Feb. 1999, pp. 71-74.
Yonga, et al, “Percutaneous Transluminal Balloon Valvuloplasty for Pulmonary Valve Stenosis: Report on Six Cases,” East African Medical Journal (Kenya), Apr. 1994, pp. 232-235.
Yonga, et al, “Percutaneous Transvenous Mitral Commissurotomy in Juvenile Mitral Stenosis,” East African Medical Journal (Kenya), Apr. 2003, pp. 172-174.
Commeau et al, “Percutaneous balloon dilatation of calcific aortic valve stenosis: anatomical and haemodynamic evaluation,” 1988, British Heart Journal, 59:227-238.
Stassano et al., “Mid-term results of the valve-on-valve technique for bioprosthetic failure,” Eur. J. Cardiothorac. Surg. 2000; 18:453-457.
Expert report of Dr. Nigel Buller, dated Jan. 12, 2009, Edwards LifeSciences v. Cook Biotech Inc., High Court of Justice—Chancery Division, Patents Court, United Kingdom, Claim No. HC 08CO0934 (83 pages).
Expert report of Dr. Nigel Buller, non-confidential annex—infringement, dated Jan. 12, 2009, Edwards LifeSciences v. Cook Biotech Inc., High Court of Justice—Chancery Division, Patents Court, United Kingdom, Claim No. HC 08CO0934 (12 pages).
Expert report of Dr. Rodolfo Quijano, dated Jan. 9, 2009, Edwards LifeSciences v. Cook Biotech Inc., High Court of Justice—Chancery Division, Patents Court, United Kingdom, Claim No. HC 08CO0934 (18 pages).
First Expert report of Prof. David Williams, dated Jan. 12, 2009, Edwards LifeSciences v. Cook Biotech Inc., High Court of Justice—Chancery Division, Patents Court, United Kingdom, Claim No. HC 08CO0934 (41 pages).
First Expert report of Prof. Martin Rothman, dated Jan. 12, 2009, Edwards LifeSciences v. Cook Biotech Inc., High Court of Justice—Chancery Division, Patents Court, United Kingdom, Claim No. HC 08CO0934 (64 pages).
Fourth Expert report of Prof. Martin Rothman, dated Apr. 22, 2009, Edwards LifeSciences v. Cook Biotech Inc., High Court of Justice—Chancery Division, Patents Court, United Kingdom, Claim No. HC 08CO0934 (10 pages).
Second Expert report of Dr. Nigel Buller, dated Feb. 25, 2009, Edwards LifeSciences v. Cook Biotech Inc., High Court of Justice—Chancery Division, Patents Court, United Kingdom, Claim No. HC 08CO0934 (24 pages).
Second Expert report of Dr. Rodolfo Quijano, dated Feb. 26, 2009, Edwards LifeSciences v. Cook Biotech Inc., High Court of Justice—Chancery Division, Patents Court, United Kingdom, Claim No. HC 08CO0934 (6 pages).
Second Expert report of Prof. David Williams, dated Feb. 5, 2009, Edwards LifeSciences v. Cook Biotech Inc., High Court of Justice—Chancery Division, Patents Court, United Kingdom, Claim No. HC 08CO0934 (15 pages).
Second Expert report of Prof. Martin Rothman, dated Feb. 5, 2009, Edwards LifeSciences v. Cook Biotech Inc., High Court of Justice—Chancery Division, Patents Court, United Kingdom, Claim No. HC 08CO0934 (11 pages).
Third Expert report of Dr. Nigel Buller, dated Apr. 21, 2009, Edwards LifeSciences v. Cook Biotech Inc., High Court of Justice—Chancery Division, Patents Court, United Kingdom, Claim No. HC 08CO0934 (6 pages).
Third Expert report of Dr. Rudolfo Quijano, dated Apr. 27, 2009, Edwards LifeSciences v. Cook Biotech Inc., High Court of Justice—Chancery Division, Patents Court, United Kingdom, Claim No. HC 08CO0934 (3 pages).
Third Expert report of Prof. David Williams, dated Apr. 22, 2009, Edwards LifeSciences v. Cook Biotech Inc., High Court of Justice—Chancery Division, Patents Court, United Kingdom, Claim No. HC 08CO0934 (9 pages).
Pavcnik et al., “Aortic and venous valve for percutaneous insertion,” Min. Invas. Ther. & Allied Techol. 2000, vol. 9, pp. 287-292.
First Expert report of Dr. Nigel Person Buller (30 pages), Corevalve, Inc. v. Edwards Lifesciences AG and Edwards Lifesciences PVT, Inc., High Court of Justice—Chancery Division Patents Court, United Kingdom, Case No. HC-07-C01243.
Second Expert report of Dr. Nigel Person Buller (5 pages), Corevalve, Inc. v. Edwards Lifesciences AG and Edwards Lifesciences PVT, Inc., High Court of Justice—Chancery Division Patents Court, United Kingdom, Case No. HC-07-C01243.
Drawing by Dr. Buller (Edwards Expert) of his interpretation of the “higher stent” referred to at col. 8, lines 13-222 of Andersen EP 592410B1 (1 page), Corevalve, Inc. v. Edwards Lifesciences AG and Edwards Lifesciences PVT, Inc., High Court of Justice—Chancery Division Patents Court, United Kingdom, Case No. HC-07-C01243.
Drawing by Dr. Buller (Edwards Expert) of “higher stent” on the schematic representation of the aortic valve area set out in Figure 2 of Rothman's first expert report (1 page), Corevalve, Inc. v. Edwards Lifesciences AG and Edwards Lifesciences PVT, Inc., High Court of Justice—Chancery Division Patents Court, United Kingdom, Case No. HC-07-C01243.
First Expert report of Professor John R. Pepper (20 pages), Corevalve, Inc. v. Edwards Lifesciences AG and Edwards Lifesciences PVT, Inc., High Court of Justice—Chancery Division Patents Court, United Kingdom, Case No. HC-07-C01243.
Second Expert report of Professor John R. Pepper (3 pages), Corevalve, Inc. v. Edwards Lifesciences AG and Edwards Lifesciences PVT, Inc., High Court of Justice—Chancery Division Patents Court, United Kingdom, Case No. HC-07-C01243.
First Expert report of Dr. Anthony C. Lunn (7 pages), Corevalve, Inc. v. Edwards Lifesciences AG and Edwards Lifesciences PVT, Inc., High Court of Justice—Chancery Division Patents Court, United Kingdom, Case No. HC-07-C01243.
First Witness statement of Stanton Rowe (9 pages), Corevalve, Inc. v. Edwards Lifesciences AG and Edwards Lifesciences PVT, Inc., High Court of Justice—Chancery Division Patents Court, United Kingdom, Case No. HC-07-C01243.
Second Witness statement of Stanton Rowe (3 pages), Corevalve, Inc. v. Edwards Lifesciences AG and Edwards Lifesciences PVT, Inc., High Court of Justice—Chancery Division Patents Court, United Kingdom, Case No. HC-07-C01243.
PVT slides naming Alain Cribier, Martin Leon, Stan Rabinovich and Stanton Rowe (16 pages), Corevalve, Inc. v. Edwards Lifesciences AG and Edwards Lifesciences PVT, Inc., High Court of Justice—Chancery Division Patents Court, United Kingdom, Case No. HC-07-C01243.
First Expert report of Professor Martin Terry Rothman (75 pages), Corevalve, Inc. v. Edwards Lifesciences AG and Edwards Lifesciences PVT, Inc., High Court of Justice—Chancery Division Patents Court, United Kingdom, Case No. HC-07-C01243.
Reply Expert report of Professor Martin Terry Rothman (9 pages), Corevalve, Inc. v. Edwards Lifesciences AG and Edwards Lifesciences PVT, Inc., High Court of Justice—Chancery Division Patents Court, United Kingdom, Case No. HC-07-C01243.
First Expert report of Richard A. Hillstead (41 pages), Corevalve, Inc. v. Edwards Lifesciences AG and Edwards Lifesciences PVT, Inc., High Court of Justice—Chancery Division Patents Court, United Kingdom, Case No. HC-07-C01243.
Reply Expert report of Richard A. Hillstead (9 pages), Corevalve, Inc. v. Edwards Lifesciences AG and Edwards Lifesciences PVT, Inc., High Court of Justice—Chancery Division Patents Court, United Kingdom, Case No. HC-07-C01243.
Expert Rebuttal Report of Prof. Martin T. Rothman (32 pages) redacted, Edwards v. CoreValve, U.S. District Court, District of Delaware, Case No. 08-091, dated Jul. 29, 2009.
Expert Report of Prof. Martin T. Rothman (74 pages ) redacted, Edwards v. CoreValve, U.S. District Court, District of Delaware, Case No. 08-091, dated Jun. 29, 2009.
Related Publications (1)
Number Date Country
20100100167 A1 Apr 2010 US